1) Product Name: NSI-189  

2) Specification: 99%

3) Testing Method: HPLC

4) Appearance: White powder

5)CAS:1270138-40-3

6)MF:C22H30N4O

Introduction:

NSI-189 is neurogenic and nootropic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer’s disease and age-related cognitive problems.

Function:

NSI-189 is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, an area of the brain believed to be contributory in MDD and other conditions, such as Alzheimer’s disease and Post-traumatic stress disorder (PTSD). Phase 1b of the clinical trial is to test the safety and tolerability of depressed patients.

Sales manager: Effy

Phone No.:86 18861112317

Skype: live:effy_71

Whatsapp: 86 18861112317

Wechat: 8618861112317

ANY INQUIRY IS WELCOME! 

WITH US, YOUR MONEY IN SAFE, YOUR BUSINESS IN SAFE